GoodRx Holdings, Inc. 8-K

What Happened

• GoodRx Holdings, Inc. filed an 8-K (Item 5.02) reporting that director Ian T. Clark resigned from the Board and the Nominating & Governance Committee effective March 31, 2026. Mr. Clark stated his resignation was not due to any disagreement with the company or management.
• To rebalance board class membership after Mr. Clark's departure, the Board moved Wendy Barnes (Chief Executive Officer and President) from Class I (term expiring at the 2027 annual meeting) to Class III (term expiring at the 2026 annual meeting). Ms. Barnes submitted a resignation as a Class I director effective upon her re-election as a Class III director; her Board service is treated as uninterrupted. The Board now has three directors in each of Classes I, II and III. The report was signed April 3, 2026, by CFO Christopher McGinnis.

Key Details

• Director resignation: Ian T. Clark, effective March 31, 2026; no disagreement with management reported.
• Board reclassification: Wendy Barnes moved from Class I (term to 2027) to Class III (term to 2026); resignation and immediate re-election executed April 1–2, 2026.
• Board composition: now three directors in each of Classes I, II and III.
• Filing date/signature: 8-K filed April 3, 2026; signed by Christopher McGinnis, CFO & Treasurer.

Why It Matters

• Board composition changes can affect corporate governance and the timing of director elections; reassigning the CEO between board classes rebalances director terms ahead of upcoming annual meetings.
• The filing confirms the change was procedural (to rebalance classes) and not prompted by a dispute, which is relevant for investors monitoring management stability and governance.